Brooks Laboratories Limited (NSE:BROOKS)
65.52
-1.54 (-2.30%)
Jan 23, 2026, 3:29 PM IST
Brooks Laboratories Revenue
Brooks Laboratories had revenue of 234.51M INR in the quarter ending September 30, 2025, with 12.79% growth. This brings the company's revenue in the last twelve months to 927.94M, up 18.67% year-over-year. In the fiscal year ending March 31, 2025, Brooks Laboratories had annual revenue of 825.57M with 3.86% growth.
Revenue (ttm)
927.94M
Revenue Growth
+18.67%
P/S Ratio
2.08
Revenue / Employee
2.87M
Employees
323
Market Cap
1.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 825.57M | 30.71M | 3.86% |
| Mar 31, 2024 | 794.86M | 162.81M | 25.76% |
| Mar 31, 2023 | 632.05M | -279.80M | -30.69% |
| Mar 31, 2022 | 911.85M | 139.38M | 18.04% |
| Mar 31, 2021 | 772.47M | 75.58M | 10.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nectar Lifesciences | 16.70B |
| Ind-Swift Laboratories | 5.72B |
| Sigachi Industries | 5.09B |
| Sakar Healthcare | 2.04B |
| Valiant Laboratories | 1.86B |
| Bafna Pharmaceuticals | 1.42B |
| Vaishali Pharma | 1.17B |
| Alpa Laboratories | 1.11B |